Key result
Anticardiolipin antibodies were present in 49% of patients with rheumatoid arthritis compared to 0% of control patients with osteoarthritis.
Why the study?
What is the prevalence and clinical association of anticardiolipin antibodies in patients with rheumatoid arthritis compared to osteoarthritis?
Case-Control (n=120)
What is the prevalence and clinical association of anticardiolipin antibodies in patients with rheumatoid arthritis compared to osteoarthritis?
Anticardiolipin antibodies are highly prevalent in rheumatoid arthritis patients compared to osteoarthritis controls and are associated with male sex, extra-articular manifestations, and elevated CRP.
Answers are grounded in this paper and cite their sources.
Should not yet inform aPL testing in rheumatoid arthritis; leaves open links to extra-articular features for prospective validation.
Anticardiolipin antibody (ACA) was present in the sera of 49% of 90 consecutive patients with rheumatoid arthritis (RA). The ACA was absent in 30 control patients with osteoarthritis. C-reactive protein levels equal to or exceeding 7 mg/dl were found in 10 patients all of whom were ACA positive. ACA was present in a larger proportion of rheumatoid factor (RF) positive than of RF negative patients. Male sex and extra-articular manifestations of RA were both more common in ACA positive than ACA negative patients. In the ACA positive group the lupus anticoagulant and VDRL tests were negative. However, a small number of patients had evidence of vascular events.
No takes yet. Share an insight, caveat, or question.
KEANE et al. (1987) conducted a case-control in Rheumatoid arthritis (n=120). Rheumatoid arthritis vs. Osteoarthritis was evaluated on Presence of anticardiolipin antibody (ACA). Anticardiolipin antibodies were present in 49% of patients with rheumatoid arthritis compared to 0% of control patients with osteoarthritis.
Synapse has enriched 10 related papers. Consider them for comparative context: